{"id":102718,"date":"2024-10-18T13:30:48","date_gmt":"2024-10-18T13:30:48","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/astm-f2211-5\/"},"modified":"2024-10-24T21:24:13","modified_gmt":"2024-10-24T21:24:13","slug":"astm-f2211-5","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/astm\/astm-f2211-5\/","title":{"rendered":"ASTM-F2211"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | Scope Referenced Documents Terminology <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | Significance and Use Classification of Tissue Engineered Medical Products Components <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Characterization of TEMP Interactions <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | Assessment (under jurisdiction of Subcommittee F04.47) Normal Biology (under jurisdiction of Subcommittee F04.41) Delivery Systems (under jurisdiction of Subcommittee F04.46) <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Microbiological Safety and Adventitious Agents (under jurisdiction of Subcommittee F04.49) Clinical Trials (under jurisdiction of Subcommittee F04.48) <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Keywords X1. RATIONALE X1.1 X1.2 X2. BACKGROUND X2.1 Background of Tissue Engineering X2.2 Scopes of Division IV Tissue Engineered Medical Products <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | X2.3 Human Systems X2.4 Aspects of TEMPs X2.5 TEMPs Examples <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | REFERENCES FIG. X2.1 <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" F2211-02 Standard Classification for Tissue Engineered Medical Products (TEMPs)<\/b><\/p>\n |